Mixed options sentiment in Novo Nordisk (NVO), with shares down 72c near $58.20. Options volume relatively light with 16k contracts traded and calls leading puts for a put/call ratio of 0.4, compared to a typical level near 0.64. Implied volatility (IV30) dropped 1.0 near 51.51,and above the 52wk median, suggesting an expected daily move of $1.89. Put-call skew steepened, indicating increased demand for downside protection.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- West Pharmaceutical price target lowered to $320 from $390 at Evercore ISI
- Novo Nordisk’s CagriSema Tops Semaglutide in Major Phase 3 Diabetes Trial
- Novo Nordisk says CagriSema users achieved weight loss of up to 14.2% in trial
- Novo Nordisk data shows CagriSema ‘superior’ in Phase 3 trial, says UBS
- Options Volatility and Implied Earnings Moves This Week, February 02 – February 06, 2026